Royal Bank of Canada
VTAE

Royal Bank of Canada’s VITAE PHARMACEUTICALS INC COMMON STOCK VTAE Stock Holding History

Royal Bank of Canada’s Portfolio VTAE Stock Details VTAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-6,500
Closed -$136K – 6984
2016
Q3 		$136K Buy
+6,500
New +$74.9K ﹤0.01% 4663
2015
Q4 		– Sell
-612
Closed -$7K – 7062
2015
Q3 		$7K Sell
612
-383
-38% -$4.07K ﹤0.01% 6079
2015
Q2 		$14K Buy
+995
New +$13.5K ﹤0.01% 5921
2015
Q1 		– Sell
-18
Closed – – 6614
2014
Q4 		$0 Buy
+18
New +$263 ﹤0.01% 6442

Royal Bank of Canada's VTAE Position: Q4 2016 in Review

Royal Bank of Canada sold out of VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) in Q4 2016, closing a stake of 6,500 shares — an estimated $136K sold.

Royal Bank of Canada first reported a position in VTAE in Q4 2014 and held it in 4 quarters. The position peaked at $136K in Q3 2016. 0 funds tracked by Wall St. Rank hold VTAE as of Q4 2016.

  • Royal Bank of Canada reported no remaining VITAE PHARMACEUTICALS INC COMMON STOCK position as of Q4 2016 after selling out during the quarter.
  • Royal Bank of Canada sold 6,500 VITAE PHARMACEUTICALS INC COMMON STOCK shares in Q4 2016, an estimated $136K.
  • Royal Bank of Canada first reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK in Q4 2014 and held it in 4 quarters.
  • Royal Bank of Canada's VITAE PHARMACEUTICALS INC COMMON STOCK position peaked at $136K in Q3 2016.
  • 0 funds tracked by Wall St. Rank held VITAE PHARMACEUTICALS INC COMMON STOCK as of Q4 2016.

Based on Royal Bank of Canada's 13F filing for Q4 2016, filed 14 Feb 2017.